Isolation of an unknown metabolite of capecitabine, an oral 5-fluorouracil prodrug, and its identification by nuclear magnetic resonance and liquid chromatography–tandem mass spectrometry as a glucuroconjugate of 5′-deoxy-5-fluorocytidine, namely 2′-(β-d-glucuronic acid)–5′-deoxy-5-fluorocytidine